Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis
- PMID: 7674230
Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis
Abstract
Objective: To assess the effect of low doses of corticosteriods on the bone mineral density (BMD) of patients with rheumatoid arthritis (RA).
Methods: A cross sectional study of BMD as measured by dual photon x-ray of the femoral neck and lumbar spine (lateral view) in 139 patients with RA followed in a university setting.
Results: The mean daily dose of prednisone taken by the study group was 4.15 mg/day. Patients receiving daily doses of prednisone between 1 to 4 mg/day had similar BMD to patients who were not receiving corticosteroids, but patients taking 5-9 mg/day and those taking > 10 mg/day had significantly lower BMD of the lumbar spine (84.28 and 80.51% of controls, respectively) than patients who received 1-4 mg/day (99.16% of controls). The effect of corticosteroids remained significant when other risk factors such as disease severity, disease duration, functional class, and activity level were controlled for. No significant relationship between prednisone dose and BMD of the femoral neck was seen at the low doses studied.
Conclusion: Low dose corticosteroid use has a significant effect on BMD of the lumbar spine.
Similar articles
-
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.J Rheumatol. 2000 Nov;27(11):2582-9. J Rheumatol. 2000. PMID: 11093437
-
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.Rheumatology (Oxford). 2005 Dec;44(12):1546-8. doi: 10.1093/rheumatology/kei082. Epub 2005 Nov 1. Rheumatology (Oxford). 2005. PMID: 16263785 Clinical Trial.
-
Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis.J Rheumatol. 1991 Mar;18(3):339-44. J Rheumatol. 1991. PMID: 1856804
-
Limited bone loss due to corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases.J Rheumatol. 1997 Aug;24(8):1495-503. J Rheumatol. 1997. PMID: 9263141
-
The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials.Bone. 2018 Sep;114:172-180. doi: 10.1016/j.bone.2018.06.008. Epub 2018 Jun 18. Bone. 2018. PMID: 29913256
Cited by
-
The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis.Rheumatol Int. 2003 Sep;23(5):231-5. doi: 10.1007/s00296-003-0298-z. Epub 2003 Mar 21. Rheumatol Int. 2003. PMID: 14504915 Clinical Trial.
-
Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity.Rheumatol Int. 2012 Mar;32(3):749-57. doi: 10.1007/s00296-010-1638-4. Epub 2010 Dec 16. Rheumatol Int. 2012. PMID: 21161535
-
Prevention and treatment of systemic glucocorticoid side effects.Int J Dermatol. 2010 Mar;49(3):239-48. doi: 10.1111/j.1365-4632.2009.04322.x. Int J Dermatol. 2010. PMID: 20465658 Free PMC article. Review.
-
Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population.Osteoporos Int. 2003 Jun;14(4):312-9. doi: 10.1007/s00198-002-1365-0. Epub 2003 Apr 16. Osteoporos Int. 2003. PMID: 12730749
-
Management of bone disease in patients on long term glucocorticoid therapy.Gut. 1999 Jun;44(6):770-2. doi: 10.1136/gut.44.6.770. Gut. 1999. PMID: 10323872 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical